Zdravookhraneniye 2023, Moscow, Russia, is organized by ZAO Exhibitions, Russia, and Messe Düsseldorf, Germany. Zdravookhraneniye is one of the largest medical and rehabilitation exhibitions in Russia and one of the largest medical and rehabilitation exhibitions in the world. It has become the largest, most professional and far-reaching medical exhibition in Russia. The exhibition covers almost the entire healthcare sector, from the development to the production of medical devices, from research to their practical application in medicine. Every year the exhibition attracts top medical companies and organizations from all over the world.
RENDER brought its self-developed products to Moscow to make a dazzling debut, including the world's first completely automatic Thromboelastography (ITEG series), POCT Chemiluminescence Immunoassay analyzer (ICL series), and other devices.
The principle is based on the strength and stability of blood clots and other physical characteristics to diagnose whether they have a normal coagulation function. "Full Series Of Thromboelastography," from platelet aggregation, coagulation, fibrinolysis, and other entire dynamic processes to monitor the coagulation process of the analyzer. simple to use and appropriate for all therapeutic circumstances.
The POCT Chemiluminescent Immunoassay Analyzer ICL-6E is an immunoassay system that is fully automated, accurate, and quantitative. The ICL-6E is separated into three groups of independent channels, and its quick and simple operation makes it suited for use in clinical laboratories as well as at the bedside. The system uses a liquid-free circuit system, and the reagent strips are disposable reagent strips in sealed packaging to prevent reagent residue, cross-infection, and contamination.
The Render worldwide team welcomed clients from all over the world with a professional and enthusiastic service attitude, patiently showing them how to operate the product so that they could better comprehend its performance and benefits, and won high appreciation and recognition.
RENDER prioritizes value creation, invests in creative research and development, and aspires to be a platform enterprise in the field of worldwide blood transfusion diagnosis and treatment. The exhibition is still open; please come and see us!